ABSI - Absci Corporation Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Absci - graphic logo of issuer ABSI

This price action chart on the GURU.Markets platform illustrates the performance of Absci (ABSI), which integrates generative AI and robotics to accelerate antibody design, with an EV/EBITDA metric of 0.00. The business relies on leasing external cloud computing and outsourcing logistics to focus on drug discovery. Despite massive R&D expenditures and a lack of profitability, alliances with the largest pharmaceutical behemoths mitigate the risks.

Absci Corp - ABSI Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/10/2026)
Product sample of absci.com

The integration of AI into antibody design at Absci makes the EV/EBITDA valuation trend a key tool for analyzing the value of this high-tech asset. This multiple compares the total enterprise value, including debt, with its operating profit before depreciation and amortization. The calculation determines the real price of the business, stripped of tax and credit effects. For an investor, an increase in this metric signals inflated market expectations regarding future earnings.

Analysis of competing companies

EV/EBITDA Multiple VEEV (Veeva Systems Inc)|Doximity Network - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HQY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio waystar.com WAY|CRVL: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Privia Health Group, Inc.|HURN (Huron Consulting) - EV/EBITDA Multiple|Certara Software (CERT) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple OMCL|EV/EBITDA Multiple goodrx.com (GDRX)|EV/EBITDA Multiple SDGR (Schrödinger)|Phreesia Inc - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|OMDA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Evolent Corp EVH|HSTM: EV/EBITDA Multiple|DH - Total Company Value to Operating Income Before Depreciation Ratio|CCSI (Consensus Cloud Solutions, Inc.) - EV/EBITDA Multiple|agilon health, inc. (AGL) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio SY (SoYoung)|Enterprise Value to Operating Income Before Depreciation Ratio NRC|Spok Holdings, Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation OPRX|TBRG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Simulations Plus Inc (SLP) - Enterprise Value to EBITDA Ratio|SOPH: EV/EBITDA Multiple|Company Value to EBITDA Health Catalyst Inc (HCAT)|CCLD (CareCloud Inc.) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation RSSS (researchsolutions.com)|EV/EBITDA Multiple DLHC|EV/EBITDA Multiple onemednet.com (ONMD)|EV/EBITDA Multiple SCNX (Scienture Holdings Inc.)|Healthcare Triangle Corporation - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ISPC - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Bullfrog AI Holdings BFRG|WORX: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MSP Recovery Inc.|ICCT (iCoreConnect, Inc.) - EV/EBITDA Multiple|TRxADE Health Corp (MEDS) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ORGS|EV/EBITDA Multiple r1rcm.com (RCM)|EV/EBITDA Multiple SHCR (Sharecare)|Streamline Health Solutions, Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SYRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Apollo Medical Holdings AMEH|MODN: EV/EBITDA Multiple|NXGN - Total Company Value to Operating Income Before Depreciation Ratio